• Dermot Murnaghan Reveals Stage IV Prostate Cancer Diagnosis and is “responding positively” to treatment.
• He encourages men—particularly those over 50 or in high‑risk categories—to request PSA tests and push for regular screenings.
• Recent treatment advances and new therapies are improving Stage IV outcomes significantly.
• This September, Dermot will participate in the Tour de 4 charity bike event in Glasgow to promote awareness and assist cancer charities.

Renowned broadcaster Dermot Murnaghan, who spent 16 years at Sky News, has disclosed that he’s battling Stage IV prostate cancer. The 67-year-old shared this personal news in a heartfelt post on X, stating,

“I’ve been diagnosed with Stage IV advanced prostate cancer…but I’m responding well to their excellent treatment and feeling good.”

Despite the seriousness of his condition, Murnaghan is extremely grateful for the exceptional care he’s received from his medical team, alongside the steadfast support from his wife, Maria Keegan, their four children, and close friends.

A Personal Update from Dermot

Murnaghan’s touching message continues:

“I’m fortunate to have an absolutely incredible medical team…offering the best possible care with expertise, compassion, and sensitivity…I feel truly blessed to be enveloped by the immense love and support of my wife, family, and dear friends.”

He’s staying active and planning to take part in Sir Chris Hoy’s Tour de 4 charity bike ride in Glasgow this September. This event aims not only to shift perceptions about Stage IV cancer but also to raise crucial funds for cancer charities.

Some personal news……I’ve been diagnosed with Stage IV advanced prostate cancer I’m fortunate to have a simply outstanding medical team looking after me, who I can’t thank enough – they are administering the best possible care with expertise, compassion and sensitivity.

— Dermot Murnaghan (@DermotMurnaghan) June 23, 2025

Why This Matters: The Importance of Early Detection

Detecting cancer early, including prostate cancer, dramatically increases the chances of successful treatment and long-term survival. For example, the five-year survival rate for localized prostate cancer is nearly 100%, but this rate drops sharply if the cancer has spread to other parts of the body. Early-stage detection also means that cancers like breast, bowel, and lung have much higher survival rates compared to late-stage diagnoses.

Prostate Cancer Basics

Prostate cancer often doesn’t show any signs in its early stages, becoming riskier once it spreads beyond the prostate. Around one in eight men in the UK will develop this illness at some point in their life.

Stage IV means the cancer has spread, potentially impacting nearby organs or bones. While the UK currently lacks a national screening program, men over 50, or over 45 in high-risk groups like Black men or those with a family history, can ask their GP for a PSA test.

Encouragement from Murnaghan

Murnaghan made a heartfelt appeal to men throughout the UK:

“Get yourself tested and advocate for routine prostate screening by the NHS.”

His message is especially poignant in light of recent well-known diagnoses, including Olympic cyclist Sir Chris Hoy, who also announced his Stage IV diagnosis in 2023, helping boost awareness and encourage testing.

Reduced Healthcare Costs and Burden

Treating cancer at an early stage is generally less costly and less intensive than managing advanced cancer. Early intervention can reduce the physical, emotional, and financial burden on patients, families, and healthcare systems.

Improved Quality of Life

Early treatment can minimize the risk of complications such as pain, incontinence, or other side effects associated with advanced disease and aggressive treatments. This helps patients maintain a better quality of life during and after treatment.

Empowering Individuals

Awareness and proactive screening empower individuals to take charge of their health. Understanding personal risk factors and recognizing early symptoms can lead to timely medical attention and better outcomes.

“Spotting cancer at an early stage saves lives. Diagnosing cancer when it isn’t too large and hasn’t spread means that treatment is more likely to be successful”.

Dermot’s Reputation: A Career in Broadcasting

Murnaghan has been a prominent figure in British television journalism since the 1980s, having worked with Channel 4, ITV, the BBC, and finally Sky News. He has covered major events, such as Princess Diana’s death, the 2019 general election, and the funerals of Prince Philip and Queen Elizabeth II in 2022.

After leaving Sky News in early 2023, he continued to host the true-crime series Killer Britain and the “Legends of News” podcast.

What’s Next for Dermot?

Looking ahead, Dermot is not only focused on his treatment but also on advocacy. He’s preparing for the Tour de 4 charity ride on September 7 in Glasgow, hosted by Sir Chris Hoy.

This endurance event aims to raise awareness and funds for cancer charities while symbolizing hope—that a Stage IV cancer diagnosis isn’t the end.

Historical Perspective: Changing the Conversation

Celebrities sharing their prostate cancer experiences have made a significant impact. When Sir Chris Hoy publicly disclosed his Stage IV diagnosis in 2023, there was an incredible eight-fold increase in searches for prostate cancer symptoms on NHS Digital.

Conversely, cancer research is advancing. Five-year survival rates for prostate cancer now exceed 90% in many regions, thanks to improved detection methods and personalized treatments.

Additionally, research into innovative therapies—such as combining hormone therapy with chemotherapy and exploring immunotherapy—has provided new hope.

Don’t Miss | Kylian Mbappé Hospitalized Due to Sudden Illness

Soundhealthandlastingwealth.com offer the most up-to-date information from top experts, new research, and health agencies, but our content is not meant to be a substitute for professional guidance. When it comes to the medication you’re taking or any other health questions you have, always consult your healthcare provider directly.